Simona Frezzini
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Sacituzumab govitecan in a triple-negative breast cancer patient journey: a cutting-edge story.
Journal: Recenti progressi in medicina
Published: November 17, 2024
PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review.
Journal: International journal of molecular sciences
Published: June 23, 2024
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Journal: Critical reviews in oncology/hematology
Published: February 10, 2022
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 17, 2021
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 01, 2021
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 04, 2020
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer.
Journal: Journal of clinical medicine
Published: December 20, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Journal: The breast journal
Published: October 07, 2019
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.
Journal: Cell death & disease
Published: March 04, 2019
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Journal: British journal of cancer
Published: February 28, 2019
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease.
Journal: Frontiers in oncology
Published: January 24, 2019
Last Updated: 09/26/2026